| Year |
Citation |
Score |
| 2012 |
Ding X, Sanchez DJ, Shahangian A, Al-Shyoukh I, Cheng G, Ho CM. Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity. International Journal of Nanomedicine. 7: 2281-92. PMID 22654513 DOI: 10.2147/Ijn.S27540 |
0.631 |
|
| 2009 |
Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. The Journal of Clinical Investigation. 119: 1910-20. PMID 19487810 DOI: 10.1172/Jci35412 |
0.707 |
|
| 2009 |
Miyahira AK, Shahangian A, Hwang S, Sun R, Cheng G. TANK-binding kinase-1 plays an important role during in vitro and in vivo type I IFN responses to DNA virus infections. Journal of Immunology (Baltimore, Md. : 1950). 182: 2248-57. PMID 19201879 DOI: 10.4049/Jimmunol.0802466 |
0.752 |
|
| 2008 |
Cheng LS, Hwang S, Huang TH, Sheu TC, Sun R, Morrison SL, Cheng G, Shahangian A. Antibody-fused interferons as an effective approach to enhance target specificity and antiviral efficacy of type I interferons. Cell Research. 18: 1230-2. PMID 19002159 DOI: 10.1038/Cr.2008.304 |
0.5 |
|
| 2008 |
Wong PK, Yu F, Shahangian A, Cheng G, Sun R, Ho CM. Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm. Proceedings of the National Academy of Sciences of the United States of America. 105: 5105-10. PMID 18356295 DOI: 10.1073/Pnas.0800823105 |
0.494 |
|
| 2008 |
Sanchez DJ, Miranda D, Arumugaswami V, Hwang S, Singer AE, Senaati A, Shahangian A, Song MJ, Sun R, Cheng G. A repetitive region of gammaherpesvirus genomic DNA is a ligand for induction of type I interferon. Journal of Virology. 82: 2208-17. PMID 18077715 DOI: 10.1128/Jvi.01718-07 |
0.675 |
|
| 2006 |
Chow EK, Castrillo A, Shahangian A, Pei L, O'Connell RM, Modlin RL, Tontonoz P, Cheng G. A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. The Journal of Experimental Medicine. 203: 2589-602. PMID 17074929 DOI: 10.1084/Jem.20060929 |
0.729 |
|
| 2006 |
Saha SK, Pietras EM, He JQ, Kang JR, Liu SY, Oganesyan G, Shahangian A, Zarnegar B, Shiba TL, Wang Y, Cheng G. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. The Embo Journal. 25: 3257-63. PMID 16858409 DOI: 10.1038/Sj.Emboj.7601220 |
0.652 |
|
| 2006 |
Miller LS, O'Connell RM, Gutierrez MA, Pietras EM, Shahangian A, Gross CE, Thirumala A, Cheung AL, Cheng G, Modlin RL. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity. 24: 79-91. PMID 16413925 DOI: 10.1016/J.Immuni.2005.11.011 |
0.692 |
|
| 2006 |
Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature. 439: 208-11. PMID 16306936 DOI: 10.1038/Nature04374 |
0.726 |
|
| 2003 |
Dadgostar H, Doyle SE, Shahangian A, Garcia DE, Cheng G. T3JAM, a novel protein that specifically interacts with TRAF3 and promotes the activation of JNK(1). Febs Letters. 553: 403-7. PMID 14572659 DOI: 10.1016/S0014-5793(03)01072-X |
0.706 |
|
| Show low-probability matches. |